Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Return on Invested Capital (2016 - 2023)

Historic Return on Invested Capital for Amicus Therapeutics (FOLD) over the last 15 years, with Q3 2025 value amounting to 0.15%.

  • Amicus Therapeutics' Return on Invested Capital fell 1700.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year decrease of 1700.0%. This contributed to the annual value of 0.09% for FY2024, which is 2300.0% up from last year.
  • According to the latest figures from Q3 2025, Amicus Therapeutics' Return on Invested Capital is 0.15%, which was down 1700.0% from 0.06% recorded in Q2 2025.
  • Amicus Therapeutics' Return on Invested Capital's 5-year high stood at 0.7% during Q1 2025, with a 5-year trough of 0.47% in Q3 2022.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.25% (2023), whereas its average is 0.18%.
  • As far as peak fluctuations go, Amicus Therapeutics' Return on Invested Capital crashed by -1700bps in 2022, and later skyrocketed by 8300bps in 2025.
  • Quarter analysis of 5 years shows Amicus Therapeutics' Return on Invested Capital stood at 0.29% in 2021, then tumbled by -36bps to 0.4% in 2022, then soared by 64bps to 0.15% in 2023, then skyrocketed by 158bps to 0.08% in 2024, then tumbled by -281bps to 0.15% in 2025.
  • Its last three reported values are 0.15% in Q3 2025, 0.06% for Q2 2025, and 0.7% during Q1 2025.